SLC6A1 and Neurodevelopmental delay: Hopefully, future diagnostic approaches in adult patients with NDD will include genetic screening, and thereby increase the adult population of the SLC6A1. This will not only increase our knowledge on the natural history of SLC6A1-NDD but may also allow for adult patients to benefit from the drug discoveries currently being made in pediatric patients.